Hansoh Pharmaceutical Group Co Ltd
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-tumor, anti-infectives, central nervous system diseases, metabolic diseases, and other therapeutic areas. Its principal products include Mailingda, Ameile, Hansoh Xinfu, Fulaimei, Hengmu, Xinwei, Tanneng, Ameining, Oulanning, Ailanning, Zetan, Ruibote, Fulaidi, Puruian, Fulairui, Pulaile, Zefei, Xinmei, Xintai, and Gainuo drugs, as well as XINYUE and Hengsen. The company serves pharmaceutical product distributors. It has a collaborations with NiKang Therapeutics to develop and commercialize NKT2152; TiumBio to develop and commercialize TU2670 for the treatment of endometriosis, uterine fibroids and other indications; Global Health Drug Discovery Institute to develop, manufacture, and commercialize the GDI-4405 series of anti-novel coronavirus; KiOmed Pharma SA to develop and commercialize KiOmedinevsOne for the treatment of osteoarthritis; and Biotheus Inc. to develop and commercialize PM1080. The company was founded in 1995 and is headquartered in Shanghai, the People's Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd. Show More...
-
Website https://www.hspharm.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 25.85 HKD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CNY 0.26 0.28 0.33 0.47 0.47 Dividends CNY Payout Ratio % * Shares Mil 5.706 5.706 5.706 5.477 5.477 Book Value Per Share * HKD 2.36 2.38 Free Cash Flow Per Share * HKD 0.45 Return on Assets % 30.62 29.84 26.64 18.27 18.27 Financial Leverage (Average) 1.62 1.3 3.41 1.5 1.5 Return on Equity % 49.63 42.59 54.48 32.96 32.96 Return on Invested Capital % 49.65 42.55 54.41 31.24 31.24 Interest Coverage 529.96 Current Ratio 1.91 3.6 1.48 2.79 2.79 Quick Ratio 1.7 3.21 1.37 2.7 2.7 Debt/Equity